PURPOSE: To develop and validate procedure-specific risk prediction for recurrence following resection for early-stage lung adenocarcinoma (ADC) and investigate risk prediction utility in identifying patients who may benefit from adjuvant chemotherapy (ACT). BASIC PROCEDURES: In patients who underwent resection for small (
Bains, S.
Eguchi, T.
Warth, A.
Yeh, Y. C.
Nitadori, J. I.
Woo, K. M.
Chou, T. Y.
Dienemann, H.
Muley, T.
Nakajima, J.
Shinozaki-Ushiku, A.
Wu, Y. C.
Lu, S.
Kadota, K.
Jones, D. R.
Travis, W. D.
Tan, K. S.
Adusumilli, P. S.
Keywords
- adjuvant chemotherapy
- competing risks analysis
- lung cancer-specific death
- recurrence
- sublobar resection
